United States, Texas, Spring – 12/30/2019 (PRDistribution.com) — Spring, TX: December, 30 2019
– an expanding E-commerce CBD Oil Hemp Extract Brand
Megola, Inc. (OTC:MGON); a Company focused on the Health & Technology Sector is pleased to update its shareholders on its development of acquiring an emerging E-commerce CBD Oil Hemp Extract Brand named Balanced2day LLC, a Florida Corporation. Megola has signed an LOI, and is completing due diligence.
Acordy acquisition update
The merger with Acordy was not closed for two key reasons: ratification of international audits and the hurdles of importing and exporting CBD products internationally.
Management have been diligently working to fill this void with this B2D acquisition and are in final discussions with several other synergistic entities.
Megola Inc would then become a holding company.
The Company has hired a legal firm and accounting firm in order to become current with all SEC filings and be up to date on The OTC.
About Balanced2day LLC
Made in USA
Balanced2Day is an expanding E-commerce CBD Oil Hemp Extract brand designed for athletes and individuals leading active lifestyles. Every bottle of Balanced2Day SPORT is THC Free and legal in all 50 states. Started by a group of individuals which include former professional athletes who are passionate about the power of CBD products. We are pesticide-free, chemical-free, preservative-free, and THC-free. Grown and extracted in the USA, our quality CBD is fully compliant under the Kentucky Department of Agricultural Industrial Hemp Pilot Program.
At Balanced2Day our CBD is derived from Cannabis Sativa Hemp plants. While these plants share a similar family name to Marijuana, these Hemp plants produce no Tetrahydrocannabinol (THC) and contain no psychoactive effects. Our hemp is grown 100% legally under Section 7606 of the Agricultural Act of 2014 (“Farm Bill”).
For more information and to ORDER visit: www.balanced2day.com
For orders use Promo Code – MGON for an instant 20% discount
The Cannabidiol (CBD) market
CBD is one of the more than 85 cannabinoids so far identified in marijuana and hemp. Unlike the better-known compound tetrahydrocannabinol (THC), CBD is not psychoactive, meaning it won’t cause a high. Thousands of studies have shown that CBD possesses an array of therapeutic benefits, including antioxidant and neuroprotective properties.
Authorized Common Shares
SOURCE Megola, Inc.
For further information, contact: Eric Ottens
Disclaimer: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. Additional information respecting the factors that could materially affect the Company and its operations are contained in its annual report on Form 10K and Form 10-Q as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statement.